The information highlighted (if any) are the most recent updates for this brand.
Febuxostat is indicated for: The treatment of chronic hyperuricemia in conditions where urate deposition has already occurred (including a history, or presence of tophus and/or gouty arthritis); The prevention and treatment of hyperuricaemia in adult patients receiving chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (TLS).